As of 2025-07-01, the Relative Valuation of C4 Therapeutics Inc (CCCC) is (29.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.43 USD, the upside of C4 Therapeutics Inc based on Relative Valuation is -2174.8%.
The range of the Relative Valuation is (19.05) - (36.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 25.3x | 19.0x |
| Forward P/E multiples | 13.1x - 30.6x | 21.8x |
| Fair Price | (19.05) - (36.80) | (29.67) |
| Upside | -1432.4% - -2673.2% | -2174.8% |
| Date | P/E |
| 2025-06-30 | -0.98 |
| 2025-06-27 | -0.96 |
| 2025-06-26 | -1.05 |
| 2025-06-25 | -1.06 |
| 2025-06-24 | -1.07 |
| 2025-06-23 | -1.01 |
| 2025-06-20 | -0.98 |
| 2025-06-18 | -0.99 |
| 2025-06-17 | -1.02 |
| 2025-06-16 | -1.12 |
| 2025-06-13 | -1.16 |
| 2025-06-12 | -1.11 |
| 2025-06-11 | -1.05 |
| 2025-06-10 | -1.08 |
| 2025-06-09 | -1.16 |
| 2025-06-06 | -1.19 |
| 2025-06-05 | -1.01 |
| 2025-06-04 | -1.06 |
| 2025-06-03 | -1.02 |
| 2025-06-02 | -0.91 |
| 2025-05-30 | -0.86 |
| 2025-05-29 | -0.91 |
| 2025-05-28 | -0.87 |
| 2025-05-27 | -0.89 |
| 2025-05-23 | -0.95 |
| 2025-05-22 | -0.94 |
| 2025-05-21 | -0.94 |
| 2025-05-20 | -1.02 |
| 2025-05-19 | -1.06 |
| 2025-05-16 | -0.95 |
| 2025-05-15 | -0.95 |
| 2025-05-14 | -0.94 |
| 2025-05-13 | -1.03 |
| 2025-05-12 | -1.09 |
| 2025-05-09 | -1.01 |
| 2025-05-08 | -1.06 |
| 2025-05-07 | -1.03 |
| 2025-05-06 | -0.97 |
| 2025-05-05 | -1.11 |
| 2025-05-02 | -1.20 |
| 2025-05-01 | -1.12 |
| 2025-04-30 | -1.13 |
| 2025-04-29 | -1.09 |
| 2025-04-28 | -1.11 |
| 2025-04-25 | -1.06 |
| 2025-04-24 | -1.11 |
| 2025-04-23 | -1.11 |
| 2025-04-22 | -1.07 |
| 2025-04-21 | -0.96 |
| 2025-04-17 | -0.86 |